Stocks and Investing
Stocks and Investing
Mon, August 12, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Andrew Fein Reiterated (ZNTL) at Strong Buy and Held Target at $20 on, Aug 12th, 2024
Andrew Fein of HC Wainwright & Co., Reiterated "Zentalis Pharmaceuticals, Inc." (ZNTL) at Strong Buy and Held Target at $20 on, Aug 12th, 2024.
Andrew has made no other calls on ZNTL in the last 4 months.
There are 5 other peers that have a rating on ZNTL. Out of the 5 peers that are also analyzing ZNTL, 3 agree with Andrew's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Eliana Merle of "UBS" Downgraded from Strong Buy to Hold and Decreased Target to $5 on, Thursday, June 20th, 2024
- Matthew Harrison of "Morgan Stanley" Downgraded from Buy to Hold and Decreased Target to $8 on, Tuesday, June 18th, 2024
- Derek Archila of "Wells Fargo" Downgraded from Buy to Hold and Decreased Target to $9 on, Tuesday, June 18th, 2024
These are the ratings of the 2 analyists that currently disagree with Andrew
- Matthew Biegler of "Oppenheimer" Maintained at Buy with Decreased Target to $25 on, Tuesday, June 18th, 2024
- Bradley Canino of "Stifel" Maintained at Strong Buy with Decreased Target to $10 on, Tuesday, June 18th, 2024
Contributing Sources